Register entry
Janssen Pharmaceuticals Sciences Unlimited Company
- Registered sites
- 0
- Drug products
- 21
- Live patents
- 0
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Catalogue
Marketed products
21Showing 21 of 21.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Apalutamide | POWDER | BULK INGREDIENT |
| - | Buprenorphine | POWDER | BULK INGREDIENT |
| - | Buprenorphine Hydrochloride | POWDER | BULK INGREDIENT |
| - | Darunavir Ethanolate | POWDER | BULK INGREDIENT |
| - | Esketamine | POWDER | BULK INGREDIENT |
| - | Hydromorphone Hydrochloride | POWDER | BULK INGREDIENT |
| - | Itraconazole Pellets | PELLET | DRUG FOR FURTHER PROCESSING |
| - | Methylphenidate Hydrochloride | POWDER | BULK INGREDIENT |
| - | Methylphenidate hydrochloride | POWDER | BULK INGREDIENT |
| - | Paliperidone | POWDER | BULK INGREDIENT |
| - | Rilpivirine Hydrochloride | POWDER | BULK INGREDIENT |
| - | Risperidone | POWDER | BULK INGREDIENT |
| - | Risperidone | POWDER | BULK INGREDIENT |
| - | Siltuximab DPC | SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | Talquetamab | SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | Tapentadol Hydrochloride | POWDER | BULK INGREDIENT |
| - | Ustekinumab | INJECTION | BULK INGREDIENT |
| - | golimumab | SOLUTION | BULK INGREDIENT |
| - | infliximab | SOLUTION | BULK INGREDIENT |
| - | teclistamab | INJECTION | BULK INGREDIENT |
| - | topiramate | POWDER | BULK INGREDIENT |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.